Bristol Myers Squibb Company (BMS) operates as a biopharmaceutical enterprise, managing the entire lifecycle of its therapeutic products, from initial discovery and development to manufacturing, marketing, and distribution. Its diverse portfolio includes conventional small molecule drugs, advanced biologics (which are derived from biological processes), and specialized chimeric antigen receptor (CAR-T) cell therapies. The company was established in August 1933 and maintains its corporate headquarters in Princeton, New Jersey.
| Price | $0.11 |
|---|---|
| Market cap | $224.7M |
| Sector | Healthcare |
| Industry | Medical - Pharmaceuticals |
| Exchange | NYSE |
| 52-week range | 0.023-0.2749 |
| Beta | -0.47 |
Explore CELG-RI's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.